OncoMed Pharmaceuticals Inc Research and Development Expense
OncoMed Pharmaceuticals Inc reported Research and Development Expense of $34.44 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2019-03-07
- OncoMed Pharmaceuticals Inc research and development expense for the quarter ending 2018-12-31 was $7.98M, a 6.93% decline year-over-year.
- OncoMed Pharmaceuticals Inc research and development expense for the quarter ending 2018-09-30 was $10.03M, a 17.77% decline year-over-year.
- OncoMed Pharmaceuticals Inc research and development expense for the quarter ending 2018-06-30 was $8.05M, a 46.63% decline year-over-year.
- OncoMed Pharmaceuticals Inc research and development expense for the quarter ending 2018-03-31 was $8.39M, a 65.04% decline year-over-year.
- OncoMed Pharmaceuticals Inc research and development expense for fiscal 2018 was $34.44M, a 42.44% decline from fiscal 2017.
- OncoMed Pharmaceuticals Inc research and development expense for fiscal 2017 was $59.84M, a 45.46% decline from fiscal 2016.
- OncoMed Pharmaceuticals Inc research and development expense for fiscal 2016 was $109.71M, a 18.13% increase from fiscal 2015.
- OncoMed Pharmaceuticals Inc research and development expense for fiscal 2015 was $92.87M, a 21.51% increase from fiscal 2014.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2018-12-31 | $7.98M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $18.00M derived: sum of 2 quarters · filed 2019-03-07 | $26.06M derived: sum of 3 quarters · filed 2019-03-07 | $34.44M 10-K · filed 2019-03-07 |
| 2018-09-30 | $10.03M 10-Q · filed 2018-11-01 | $18.08M derived: sum of 2 quarters · filed 2018-11-01 | $26.47M 10-Q · filed 2018-11-01 | $35.04M derived: sum of 4 quarters · filed 2019-03-07 |
| 2018-06-30 | $8.05M 10-Q · filed 2018-08-02 | $16.44M 10-Q · filed 2018-08-02 | $25.01M derived: sum of 3 quarters · filed 2019-03-07 | $37.20M derived: sum of 4 quarters · filed 2019-03-07 |
| 2018-03-31 | $8.39M 10-Q · filed 2018-05-08 | $16.96M derived: sum of 2 quarters · filed 2019-03-07 | $29.15M derived: sum of 3 quarters · filed 2019-03-07 | $44.24M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-12-31 | $8.57M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $20.76M derived: sum of 2 quarters · filed 2019-03-07 | $35.85M derived: sum of 3 quarters · filed 2019-03-07 | $59.84M 10-K · filed 2019-03-07 |
| 2017-09-30 | $12.19M 10-Q · filed 2018-11-01 | $27.28M derived: sum of 2 quarters · filed 2018-11-01 | $51.27M 10-Q · filed 2018-11-01 | $75.51M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | $15.09M 10-Q · filed 2018-08-02 | $39.08M 10-Q · filed 2018-08-02 | $63.32M derived: sum of 3 quarters · filed 2019-03-07 | $90.68M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | $23.99M 10-Q · filed 2018-05-08 | $48.23M derived: sum of 2 quarters · filed 2019-03-07 | $75.59M derived: sum of 3 quarters · filed 2019-03-07 | $105.30M derived: sum of 4 quarters · filed 2019-03-07 |
| 2016-12-31 | $24.25M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $51.61M derived: sum of 2 quarters · filed 2019-03-07 | $81.31M derived: sum of 3 quarters · filed 2019-03-07 | $109.71M 10-K · filed 2019-03-07 |
| 2016-09-30 | $27.36M 10-Q · filed 2017-11-02 | $57.07M derived: sum of 2 quarters · filed 2017-11-02 | $85.47M 10-Q · filed 2017-11-02 | $112.15M derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-06-30 | $29.71M 10-Q · filed 2017-08-02 | $58.11M 10-Q · filed 2017-08-02 | $84.79M derived: sum of 3 quarters · filed 2018-03-09 | $109.50M derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-03-31 | $28.40M 10-Q · filed 2017-05-08 | $55.08M derived: sum of 2 quarters · filed 2018-03-09 | $79.79M derived: sum of 3 quarters · filed 2018-03-09 | $101.84M derived: sum of 4 quarters · filed 2018-03-09 |
| 2015-12-31 | $26.68M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $51.40M derived: sum of 2 quarters · filed 2018-03-09 | $73.44M derived: sum of 3 quarters · filed 2018-03-09 | $92.87M 10-K · filed 2018-03-09 |
| 2015-09-30 | $24.71M 10-Q · filed 2016-11-01 | $46.76M derived: sum of 2 quarters · filed 2016-11-01 | $66.19M 10-Q · filed 2016-11-01 | $86.74M derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-06-30 | $22.05M 10-Q · filed 2016-08-09 | $41.48M 10-Q · filed 2016-08-09 | $62.03M derived: sum of 3 quarters · filed 2017-03-09 | $83.03M derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-03-31 | $19.43M 10-Q · filed 2016-05-05 | $39.99M derived: sum of 2 quarters · filed 2017-03-09 | $60.99M derived: sum of 3 quarters · filed 2017-03-09 | $79.15M derived: sum of 4 quarters · filed 2017-03-09 |
| 2014-12-31 | $20.55M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $41.55M derived: sum of 2 quarters · filed 2017-03-09 | $59.72M derived: sum of 3 quarters · filed 2017-03-09 | $76.43M 10-K · filed 2017-03-09 |
| 2014-09-30 | $21.00M 10-Q · filed 2015-11-05 | $39.17M derived: sum of 2 quarters · filed 2015-11-05 | $55.88M 10-Q · filed 2015-11-05 | $72.75M derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-06-30 | $18.17M 10-Q · filed 2015-08-10 | $34.88M 10-Q · filed 2015-08-10 | $51.75M derived: sum of 3 quarters · filed 2016-03-10 | $64.87M derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-03-31 | $16.71M 10-Q · filed 2015-05-07 | $33.58M derived: sum of 2 quarters · filed 2016-03-10 | $46.71M derived: sum of 3 quarters · filed 2016-03-10 | $57.18M derived: sum of 4 quarters · filed 2016-03-10 |
| 2013-12-31 | $16.87M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $30.00M derived: sum of 2 quarters · filed 2016-03-10 | $40.47M derived: sum of 3 quarters · filed 2016-03-10 | $50.05M 10-K · filed 2016-03-10 |
| 2013-09-30 | $13.13M 10-Q · filed 2014-11-04 | $23.60M derived: sum of 2 quarters · filed 2014-11-04 | $33.18M 10-Q · filed 2014-11-04 | $42.68M derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-06-30 | $10.47M 10-Q · filed 2014-08-07 | $20.05M 10-Q · filed 2014-08-07 | $29.55M derived: sum of 3 quarters · filed 2015-03-12 | $39.05M derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-03-31 | $9.58M 10-Q · filed 2014-05-08 | $19.08M derived: sum of 2 quarters · filed 2015-03-12 | $28.57M derived: sum of 3 quarters · filed 2015-03-12 | $38.14M derived: sum of 4 quarters · filed 2015-03-12 |
| 2012-12-31 | $9.50M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $19.00M derived: sum of 2 quarters · filed 2015-03-12 | $28.57M derived: sum of 3 quarters · filed 2015-03-12 | $39.89M 10-K · filed 2015-03-12 |
| 2012-09-30 | $9.50M 10-Q · filed 2013-11-13 | $19.07M derived: sum of 2 quarters · filed 2013-11-13 | $30.39M 10-Q · filed 2013-11-13 | |
| 2012-06-30 | $9.57M 10-Q · filed 2013-09-03 | $20.89M 10-Q · filed 2013-09-03 | ||
| 2011-12-31 | $40.06M 10-K · filed 2014-03-18 |